Nasdaq, Inc. (NDAQ) Presents at Barclays 24th Annual Global Financial Services Conference Transcript

Nasdaq CFO Sarah Youngwood described the macro and capital-markets backdrop as constructive, citing resilient consumers, earnings support for equity valuations, and continued investment in AI and digital technologies. Nasdaq recorded its strongest first half for IPO fundraising, with $111 billion raised, including $86 billion from SpaceX, indicating demand for scaled, mature public-market opportunities. The company sees a robust IPO pipeline over the next 6-12 months, though the cited fundraising total is heavily concentrated in the SpaceX transaction.

Analysis

The key earnings read-through is not aggregate issuance volume but the mix toward large, mature offerings: this supports Nasdaq’s listing, data, index, and post-trade franchises more reliably than episodic trading volumes. A healthier pipeline can improve forward revenue visibility and justify modest multiple expansion, but the benefit will be back-end loaded because listings convert only when transactions price and remain listed. The market should focus on net new listings, issuer-services recurring revenue, and the conversion rate of announced IPO candidates rather than headline proceeds.

NDAQ’s relative advantage is greatest if AI-linked and venture-backed issuers choose a public listing rather than private secondary liquidity, which also creates downstream demand for indexes, market data, surveillance, and investor-relations services. The less obvious loser is SPCX: a conventional IPO reopening reduces the scarcity value of SPACs as an alternative route to public markets, particularly for higher-quality sponsors and targets. NYSE/ICE is the direct listing competitor, while Cboe (CBOE) could benefit indirectly from higher equity-options activity after new large-cap listings, but lacks NDAQ’s issuer-services annuity.

Near term, this is insufficient alone to chase NDAQ after a strong move; conference commentary is management framing, not a guidance change. Over 1-3 months, a visible calendar of priced technology listings and upward revisions to exchange-industry issuance forecasts would be the catalyst. The thesis fails if IPO filings rise while withdrawals, discounted pricing, or first-day performance deteriorate—signaling sponsor supply rather than durable institutional demand; a volatility shock or higher real yields would likely close the issuance window quickly.

Key Decisions for Investors

• Maintain or initiate a modest long NDAQ on weakness over a 3-6 month horizon; target upside is driven by evidence of recurring issuer-services and data revenue acceleration, not one-off listing fees. Risk-manage against a material increase in IPO withdrawals or a guidance framework that does not translate pipeline into revenue.
• Express the public-listing normalization theme as long NDAQ / short SPCX over 3-6 months, sized conservatively. The spread should widen if conventional IPO pricing remains open; exit if SPAC deal completions and redemption economics improve materially relative to traditional IPO issuance.
• Do not add solely on reported IPO proceeds. Set an alert for sequential improvement in NDAQ net new listings, issuer-services organic growth, and technology-sector deal conversion; absent these data, treat management optimism as low-conviction.
• For broader beta exposure, prefer NDAQ over a pure exchange-volume trade such as CBOE if the objective is issuance-cycle participation; use a 5-7% adverse relative-performance stop, as a volatility-led market would favor transaction-volume businesses over issuance-sensitive franchises.